http://www.unboundmedicine.com/medline/ebm/research/Adenocarcinoma,_gastricUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/18831862/full_citation/Managing_acrometastases_treatment_strategy_with_a_case_illustration_Spiteri V, Bibra A, Ashwood N, et al. 
Managing acrometastases treatment strategy with a case illustration. [Journal Article]
Ann R Coll Surg Engl 2008 Oct; 90(7):W8-11.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18830123/full_citation/Pyloric_Gland_Adenoma:_An_Entity_Distinct_From_Gastric_Foveolar_Type_Adenoma_Chen ZM, Scudiere JR, Abraham SC, et al. 
Pyloric Gland Adenoma: An Entity Distinct From Gastric Foveolar Type Adenoma. [JOURNAL ARTICLE]
Am J Surg Pathol 2008 Sep 30.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18828967/full_citation/Survival_trends_in_patients_with_gastric_and_esophageal_adenocarcinomas:_a_population_based_study_Crane SJ, Locke GR, Harmsen WS, et al. 
Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. [Journal Article]
Mayo Clin Proc 2008 Oct; 83(10):1087-94.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18828905/full_citation/Adenocarcinoma_of_the_third_portion_of_the_duodenum_in_a_man_with_CREST_syndrome_Anastasopoulos G, Marinis A, Konstantinidis C, et al. 
Adenocarcinoma of the third portion of the duodenum in a man with CREST syndrome. [JOURNAL ARTICLE]
World J Surg Oncol 2008 Oct 1; 6(1):106.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18827818/full_citation/NET1_mediated_RhoA_activation_facilitates_lysophosphatidic_acid_induced_cell_migration_and_invasion_in_gastric_cancer_Murray D, Horgan G, Macmathuna P, et al. 
NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer. [JOURNAL ARTICLE]
Br J Cancer 2008 Sep 30.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18825411/full_citation/Four_consecutive_multicenter_phase_II_trials_of_adjuvant_chemoradiation_in_patients_with_completely_resected_high_risk_gastric_cancer:_the_experience_of_the_German_AIO/ARO/CAO_group_Oechsle K, Bokemeyer C, Hartmann JT, et al. 
Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group. [JOURNAL ARTICLE]
J Cancer Res Clin Oncol 2008 Sep 30.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18825311/full_citation/Endogenous_estrogen_exposure_in_relation_to_distribution_of_histological_type_and_estrogen_receptors_in_gastric_adenocarcinoma_Chandanos E, Rubio CA, Lindblad M, et al. 
Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma. [Journal Article]
Gastric Cancer 2008; 11(3):168-74.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18823376/full_citation/Somatostatin_receptor_1_induces_cell_cycle_arrest_and_inhibits_tumor_growth_in_pancreatic_cancer_Li M, Wang X, Li W, et al. 
Somatostatin receptor-1 induces cell cycle arrest and inhibits tumor growth in pancreatic cancer. [JOURNAL ARTICLE]
Cancer Sci 2008 Sep 22.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18823380/full_citation/Hepatoma_derived_growth_factor_involved_in_the_carcinogenesis_of_gastric_epithelial_cells_through_promotion_of_cell_proliferation_by_Erk1/2_activation_Mao J, Xu Z, Fang Y, et al. 
Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation. [JOURNAL ARTICLE]
Cancer Sci 2008 Sep 22.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18819876/full_citation/[FOLFOX_versus_PLF_regimen_in_treatment_of_advanced_gastric_adenocarcinoma_]Ye S, Rong J, Lin TY, et al. 
[FOLFOX versus PLF regimen in treatment of advanced gastric adenocarcinoma.] [English Abstract, Journal Article]
Nan Fang Yi Ke Da Xue Xue Bao 2008 Sep; 28(9):1599-602.
Abstract | Full Citation